Published in Gastrointest Cancer Res on November 01, 2009
Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward. Gastroenterol Res Pract (2015) 0.78
Adopting postoperative chemoradiotherapy in resected gastric cancer. Gastrointest Cancer Res (2009) 0.78
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med (2006) 26.37
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med (2001) 18.77
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med (2001) 7.59
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86
Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol (2003) 3.18
Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer (1998) 1.79
Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol (2000) 1.63
Effect of microscopic resection line disease on gastric cancer survival. J Gastrointest Surg (2000) 1.36
Adjuvant therapy for resected gastric cancer--rapid, yet incomplete adoption following results of intergroup 0116 trial. Int J Radiat Oncol Biol Phys (2007) 1.18
Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg (2000) 1.13
Gastric Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw (2006) 1.00
Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol (2006) 0.99
A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer. Chemotherapy (1997) 0.85
Evidence-based recommendations for local-regional control of gastric cancer. Cancer Invest (2005) 0.80
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA (2008) 4.61
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys (2007) 3.87
Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol (2008) 3.44
Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst (2008) 2.84
The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005. Ann Thorac Surg (2009) 2.49
Bibliometric analysis of radiation oncology departmental scholarly publication productivity at domestic residency training institutions. J Am Coll Radiol (2009) 2.33
Using complications associated with postmastectomy radiation and immediate breast reconstruction to improve surgical decision making. Arch Surg (2010) 2.11
Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol (2011) 2.10
Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol (2006) 2.07
Current status of diversity by race, Hispanic ethnicity, and sex in diagnostic radiology. Radiology (2013) 2.02
Mechanical circulatory support pathways that maximize post-heart transplant survival. Ann Thorac Surg (2012) 2.02
Melatonin: from basic research to cancer treatment clinics. J Clin Oncol (2002) 1.99
National practice patterns for management of adult congenital heart disease: operation by pediatric heart surgeons decreases in-hospital death. Circulation (2008) 1.99
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol (2012) 1.84
Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol (2008) 1.78
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy. J Clin Oncol (2009) 1.65
Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer (2007) 1.63
Predictors of technical skill acquisition among resident trainees in a laparoscopic skills education program. World J Surg (2008) 1.62
Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J Clin Oncol (2004) 1.61
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys (2006) 1.60
The rush to atrial septal defect closure: is the introduction of percutaneous closure driving utilization? Ann Thorac Surg (2008) 1.59
Profoundly abnormal initial physiologic and biochemical data cannot be used to determine futility in massively transfused trauma patients. J Trauma (2011) 1.57
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol (2011) 1.54
Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys (2004) 1.53
Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer. Arch Surg (2011) 1.51
Reoperation as a quality indicator in colorectal surgery: a population-based analysis. Ann Surg (2007) 1.51
Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg (2009) 1.50
Radiation therapy in the postoperative management of esophageal cancer. J Gastrointest Oncol (2010) 1.48
Conditional survival and the choice of conditioning set for patients with colon cancer: an analysis of NSABP trials C-03 through C-07. J Clin Oncol (2010) 1.47
Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer (2007) 1.44
Specialized practice reduces inpatient mortality, length of stay, and cost in the care of colorectal patients. Dis Colon Rectum (2011) 1.42
A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol (2013) 1.40
Conditional Survival in Anal Carcinoma Using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012). Dis Colon Rectum (2016) 1.40
Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol (2007) 1.35
Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys (2010) 1.30
Locally advanced duodenal gangliocytic paraganglioma treated with adjuvant radiation therapy: case report and review of the literature. World J Surg Oncol (2005) 1.27
Forty-eight-hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg (2005) 1.27
Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys (2004) 1.25
Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg (2004) 1.24
Utilization of laparoscopic colectomy in the United States before and after the clinical outcomes of surgical therapy study group trial. Ann Surg (2011) 1.22
Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice. Metabolism (2012) 1.22
Relative lack of conditional survival improvement in young adults with cancer. Semin Oncol (2009) 1.21
Conditional Survival in Rectal Cancer: A SEER Database Analysis. Gastrointest Cancer Res (2007) 1.21
The relationship between hospital surgical case volumes and mortality rates in pediatric cardiac surgery: a national sample, 1988-2005. Ann Thorac Surg (2008) 1.19
Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg (2009) 1.18
Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist (2004) 1.15
Patient and peri-operative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP), 2005-2008. J Gastrointest Surg (2010) 1.15
A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys (2005) 1.14
Clinical utility and cost-effectiveness of routine preoperative computed tomography scanning in patients with colon cancer. Am J Surg (2005) 1.14
Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis. Cancer (2009) 1.14
Racial disparities in mortality among adults hospitalized after injury. Med Care (2008) 1.13
Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survival. Am J Clin Oncol (2006) 1.13
Complications nearly double the cost of care after pancreaticoduodenectomy. Am J Surg (2012) 1.12
Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery (2006) 1.11
Superior sulcus tumors: a mini-review. Oncologist (2004) 1.10
Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2006) 1.10
Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer (2010) 1.09
Flawed assumptions used to defend screening mammography. Cancer (2014) 1.09
Evolution of treatment options and outcomes for hypoplastic left heart syndrome over an 18-year period. J Thorac Cardiovasc Surg (2009) 1.08
Equestrian injury prevention efforts need more attention to novice riders. J Trauma (2007) 1.07
Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist (2004) 1.05
The utility of routine preoperative computed tomography scanning in the management of veterans with colon cancer. Am J Surg (2002) 1.04
The national mortality burden and significant factors associated with open and laparoscopic cholecystectomy: 1997-2006. J Gastrointest Surg (2009) 1.03
Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol (2006) 1.02
Disparities in cancer care: a worldwide perspective and roadmap for change. J Clin Oncol (2006) 1.02
Estimation of citation-based scholarly activity among radiation oncology faculty at domestic residency-training institutions: 1996-2007. Int J Radiat Oncol Biol Phys (2008) 1.01
Multimodality approaches for pancreatic cancer. CA Cancer J Clin (2005) 1.01
Patient and hospital characteristics on the variance of perioperative outcomes for pancreatic resection in the United States: a plea for outcome-based and not volume-based referral guidelines. Arch Surg (2009) 1.00
Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis. Cancer (2010) 1.00
Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys (2004) 0.99
Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer (2008) 0.99
Adhesion molecules in radiotherapy. Radiat Res (2006) 0.97
Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin (2008) 0.96
Race, treatment, and survival of veterans with cancer of the distal esophagus and gastric cardia. Med Care (2002) 0.96
Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature. Am J Clin Oncol (2002) 0.96
Clinicians communicating with patients experiencing cancer pain. Cancer Invest (2003) 0.96
Sixty years of CA: a cancer journal for clinicians. CA Cancer J Clin (2010) 0.95
Mortality rate is not a valid indicator of quality differences between pediatric cardiac surgical programs. Ann Thorac Surg (2010) 0.95
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Invest New Drugs (2008) 0.95
A growing problem: maternal death and peripartum complications are higher in women with grown-up congenital heart disease. Ann Thorac Surg (2011) 0.95
Techniques and results of portal vein/superior mesenteric vein reconstruction using femoral and saphenous vein during pancreaticoduodenectomy. J Vasc Surg (2010) 0.94
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.94
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). J Thorac Oncol (2012) 0.93
An interactive tool for individualized estimation of conditional survival in rectal cancer. Ann Surg Oncol (2011) 0.93
Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med (2014) 0.93
Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol (2011) 0.93
Dramatic decreases in mortality from laparoscopic colon resections based on data from the Nationwide Inpatient Sample. Arch Surg (2011) 0.93
External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy. Gastroenterology (2004) 0.92
Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer. Surg Endosc (2013) 0.92
Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease--a comparison of administrative and clinical data. Cardiol Young (2008) 0.91
Stereotactic body radiation therapy: an ablative treatment option for primary and secondary liver tumors. Ann Surg Oncol (2004) 0.91
Gastric cancer: standards for the 21st century. Crit Rev Oncol Hematol (2006) 0.91
Esophageal carcinoma. N Engl J Med (2015) 0.91
Intraoperative oncologic staging and outcomes for lung cancer resection vary by surgeon specialty. Ann Thorac Surg (2011) 0.91
Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma. Arch Surg (2011) 0.91
Squamous cell carcinoma of the anal canal. Surg Oncol (2005) 0.91